Revolutionary Non‑Invasive Care
No surgery. No general anaesthesia. Just gentle, effective treatment for tumors and fibroids with a rapid recovery.
No surgery. No general anaesthesia. Just gentle, effective treatment for tumors and fibroids with a rapid recovery.
A non‑invasive alternative to surgery, HIFU uses precisely targeted ultrasound energy to destroy tissue — most commonly fibroids, adenomyosis lesions, or benign tumors — without incisions, radiation, or general anaesthesia.
Heat: Focused beams rapidly heat and destroy targeted cells while sparing surrounding tissue.
Microscopic Bubbles: At high intensity, bubbles form and collapse, mechanically disrupting cells.
As seen on BBC South Today: A report on the non-invasive HIFU technology available for treating fibroids and adenomyosis. © BBC 2026

The JC200 uses focused ultrasound — sound waves precisely converged at a single point inside the body — to heat and destroy fibroids or tumours without any surgical cuts or radiation. Treatment is guided live on screen, with clinicians moving the focal point millimetre by millimetre using a robotic arm for exceptional accuracy. Most patients require only light sedation, return home the same day, and resume normal activities within 1–2 days. Used worldwide for fibroids, adenomyosis and selected soft‑tissue tumours, the JC200 preserves surrounding healthy tissue while delivering consistent, conformal results. As Haifu’s established clinical platform, it provides reliable, image‑guided, non‑invasive therapy with proven outcomes across global centres, making it a trusted choice for hospitals seeking precision, safety and efficiency in everyday practice.

The JC300 is Haifu’s next‑generation focused ultrasound platform — a fully integrated, non‑invasive system designed for precise ablation of solid tumours across soft tissues. Like all HIFU systems, it concentrates ultrasound energy at a single point to destroy targeted tissue without incision, bleeding or radiation. Its advanced architecture sets it apart: real‑time HD imaging, multi‑axis robotic motion, red‑light positioning and a multifunctional treatment bed that enables rapid setup and accurate alignment. Clinicians guide therapy live, adjusting energy millimetre by millimetre while the system monitors tissue response in real time. Used globally for fibroids, adenomyosis and tumours of the liver, pancreas, breast, kidney and bone, the JC300 preserves surrounding structures while delivering high‑quality, image‑guided treatment. As Haifu’s flagship hospital system, it offers a comprehensive workflow and proven clinical performance across leading centres.
Main Office: 0333 335 6346 WhatsApp: 07871 905864 Email: info@adjmedical.com